Skip to content

Clinical trials

Phase 3 Alzheimer Disease trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 3 Country / region: Slovakia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20083
20093
20141
20151
20162
20171
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10
Completed6
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Axovant Sciences Ltd.2
GlaxoSmithKline2
ACADIA Pharmaceuticals Inc.1
Eisai Co., Ltd.1
H. Lundbeck A/S1
Janssen Research & Development, LLC1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Novartis Pharmaceuticals1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease17
Dementia4
Psychotic Disorders2
Cognitive Dysfunction1
Corticobasal Degeneration1
Dementia, Vascular1
Hallucinations1
Lewy Body Disease1
Lymphoma, Follicular1
Memory Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.